| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 530 | $60 | $33.6K |
| J0897 | Injection, denosumab, 1 mg | 1,020 | $20 | $18.4K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 70 | $130 | $9.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 90 | $90 | $7.6K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 60 | $130 | $7.6K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 100 | $70 | $7.2K |
| 93882 | The provider performs a duplex ultrasound scan of the carotid and/or vertebral arteries on one side. He performs the procedure to evaluate the arteries for stenosis, or narrowing, in a patient who… | 80 | $80 | $6.3K |
| G0008 | Administration of influenza virus vaccine | 110 | $30 | $3.2K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 220 | $10 | $2.6K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 70 | $40 | $2.5K |